Maintenance of delayed hypersensitivity reactions in patients receiving cancer chemotherapy.
D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005467:Floxuridine / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D007109:Immunity / Q000187:drug effects*; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D012882:Skin Tests
D005467:Floxuridine; D003520:Cyclophosphamide; D005472:Fluorouracil